Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.82B | 2.11B | 2.96B | 3.03B | 3.11B |
| Total Other Revenue | 125.00M | 121.00M | 120.00M | 149.00M | 127.00M |
| Total Revenue | 1.94B | 2.23B | 3.08B | 3.18B | 3.24B |
| Cost of Revenue | 4.00B | 4.63B | 5.28B | 5.79B | 6.01B |
| Gross Profit | -2.06B | -2.40B | -2.20B | -2.62B | -2.77B |
| SG&A Expenses | 1.02B | 1.06B | 1.07B | 1.11B | 1.17B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.02B | 5.70B | 6.35B | 6.91B | 7.18B |
| Operating Income | -3.07B | -3.46B | -3.27B | -3.73B | -3.95B |
| Income Before Tax | -2.77B | -3.15B | -2.95B | -3.41B | -3.61B |
| Income Tax Expenses | 54.00M | -37.00M | -42.00M | -49.00M | -46.00M |
| Earnings from Continuing Operations | -2.82K | -3.12K | -2.90K | -3.36K | -3.56K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.82B | -3.12B | -2.90B | -3.36B | -3.56B |
| EBIT | -3.07B | -3.46B | -3.27B | -3.73B | -3.95B |
| EBITDA | -2.86B | -3.26B | -3.07B | -3.54B | -3.76B |
| EPS Basic | -7.26 | -8.06 | -7.52 | -8.72 | -9.28 |
| Normalized Basic EPS | -4.44 | -5.08 | -4.73 | -5.45 | -5.78 |
| EPS Diluted | -7.26 | -8.07 | -7.52 | -8.73 | -9.29 |
| Normalized Diluted EPS | -4.44 | -5.08 | -4.73 | -5.45 | -5.79 |
| Average Basic Shares Outstanding | 1.56B | 1.55B | 1.54B | 1.54B | 1.54B |
| Average Diluted Shares Outstanding | 1.56B | 1.55B | 1.56B | 1.55B | 1.55B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |